Global Genomic Services Market Size By Type(pharma genomics, clinical genomics), By Geographic Scope And Forecast

Genomic Services Market Size And Forecast

Genomic Services Market size was valued at USD 5,703.67 Million in 2021 and is projected to reach USD 28,166.67 Million by 2030, growing at a CAGR of 19.34% from 2023 to 2030.

The genomics market has been recently flourishing with increased funding from private players and governments to further boost the application of genomics in several life science sectors. The Global Genomic Services Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

What is Genomic Services?

Genomics refers to the science that studies the genome of living beings. Genome studies are performed with the help of technologies that include DNA sequencing via the Sanger method or NGS (Next Generation Sequencing) which are used to map and study genes and their functions also include the identification of genes that are responsible for diseases. New and improved technologies allow genomics to accelerate; NGS (Next Generation Sequencing), genome editing techniques including CRISPR-Cas9, and quantitative technologies to measure gene expression by using qPCR and digital PCR (dPCR). DNA sequencing procedures are also evolved over the years, and can be categorized into generationsSanger method, Maxam and Gilbert method, NGS such as pyrosequencing, SOLiD sequencing, by Nanopore, etc. The Genomics Services Laboratory can assist investigators with several aspects of next-generation sequencing, which include sequence generation, experimental design, library preparation, and data analysis. The advanced bioinformatics support to analyze complex sequencing datasets, such as integrated DNA and RNA sequence data, is an expressed strength.

Global Genomic Services Market Overview

The genomics market has been recently flourishing with increased funding from private players and governments to further boost the application of genomics in several life science sectors. The stimulus to set up genome banks and genomic studies of countries, regions, and ethnicities has resulted into public–private partnerships, private firm investments, governmental investments. For instance, the deCODE genetics and Government of Iceland have partnered to perform coronavirus demonic analysis. Likewise, the Government of India is supporting Haystack Analytics in researching virus transmission by genome sequencing methods. The growing number of start-ups and similar initiatives is anticipated to boost the global genomics services market over the forecast years. For instance, in February 2019, the Minister of Science and Sports (Canada) declared funding of USD 22.7 million along with funding of USD 33.4 million by provincial governments to assist 36 projects through Genome Canada. The projects include several sectors such as agriculture, health, natural resources and the environment. Development in the personalized medicine market is expected to offer ample of opportunities for companies operating in the genomics services market. Several pharmaceutical organizations are growingly investing in research for personalized medicine. Personalized medicine allows medical practitioners to recognize the exact demands of a patient and then prescribe treatments and medicines accordingly. This approach ensures better care results. Moreover, it is expected that developments in the field of gene therapy have the ability to replace traditional surgeries and drugs by allowing doctors to treat a disorder by introducing a gene into a patient’s cell.

In spite of the huge potential, dearth of trained technicians is an important factor which is restraining the growth of the genomics services market in the developing nations. Many of the developing nations either have low number of technicians or they lack the training needed for using sophisticated sequencers. Sharing and storing genomic data has become challenging as an individual genome consumes around 100 gigabytes. After constant sequencing, the requirements reached exabytes and petabytes from gigabytes. For storing human genomic data, approximately 40 exabytes of storage can be needed by 2050 which generates a concern for data storage. Genomics data can be utilized for several applications such as toxicogenomics, diagnostics, and pharmacogenomics. But, the analysis of large volumes of data generated in genomics research is a key challenge.

Global Genomic Services MarketSegmentation Analysis

The Global Genomic Services Market is segmented on the basis of Type and geography.

Genomic Services Market by Type

• Pharma Genomics
• Clinical Genomics

To Get Summarized Market Report By Type-

Based on Type, the market is segmented into pharma genomics, clinical genomics. Pharma Genomics accounted for the largest market share in 2021 and is projected to grow at the highest CAGR during the forecast period. Pharma genomics uses genomic data to evaluate a patient’s response to specific drugs. Pharma genomics can be employed to predict negative medication reactions or decrease efficacy, resulting in better health outcomes and lower costs. New methods are being investigated in clinical trials as the field of pharmaceutical genomics expands. In the future, pharmaceutical genomics will be used to create custom medications to address a variety of medical conditions, such as cardiovascular disease, Alzheimer’s disease, cancer, and asthma. Precision medicines have been shown to be effective in the treatment of cancer. Pharma genomics and related expertise are required for the development of such drugs.

Genomic Services Market by Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of regional analysis, the Global Genomic Services Market is classified into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America accounted for the largest market share in 2021 and is projected to grow at the highest CAGR during the forecast period. Europe was the second-largest market in 2021. In North America, the primary factor driving the market growth is the increasing rate of diagnosis and majority of fibromyalgia combined with the more extensive availability of advanced approved products to manage the disease. For instance, according to the American Chronic Pain Association, 2-4% of Americans have fibromyalgia. Also, the rising focus of the competitors to launch innovative drugs in the region is counted to drive market growth. Fibromyalgia affects people physically, mentally, and socially.

Key Players

The major players in the market are Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Eurofins Scientific, PerkinElmer Genomics, Illumina, Inc. and many others.

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In April, 2022, Thermo Fisher Scientific has launched the Gibco CTA TrueCut Cas9 protein, which is made in accordance with GMP standards, to facilitate genome editing in research and production applications. The proteins are produced in accordance with USP requirements, which include traceability documentation, aseptic production, and safety testing.

• In February, 2022, Laboratory Corporation of America Holdings (LH) announced the completion of its purchase of privately held Personal Genome Diagnostics Inc, a supplier of complete liquid biopsy and tissue-based genomic products and services. Labcorp would pay USD 450 million in cash at closing and up to an additional USD 125 million if future performance criteria were met.

• In March, 2021, Eurofins Viracor BioPharma Services has announced the availability of its new PanCancerIQ genomic profiling test, which is a next-generation sequencing (NGS) service that allows for thorough genomic profiling of tumour samples. The Eurofins Viracor new PanCancerIQ test service incorporates Illumina’s TruSight Oncology 500 (TSO500) NGS technology and bioinformatics, as well as clinical interpretation via a knowledgebase established by MD Anderson Cancer Center in collaboration with Philips.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

In case of any please connect with our sales team, who will ensure that your requirements are met.